Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Tengjun Biotechnology Corp. | f10k2019ex31-1_tengjunbio.htm |
| 10-K - ANNUAL REPORT - Tengjun Biotechnology Corp. | f10k2019_tengjunbiotech.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, the Chief Executive and Financial Officer of Tengjun Biotechnology Corp. (the “Company”), certifies that, to her knowledge:
| 1. | The report of the Company for the twelve-month period ended December 31, 2019 as filed with the Securities and Exchange Commission on this date (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| /s/ Qiuping Lu | |
| Date: February 28, 2020 | Qiuping Lu |
| Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial and Accounting Officer) |